ERBB2 and breast cancer: Although the use of biomarkers in precision medicine has been mostly applied in oncological indications, such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (ER/PR/HER2) for breast cancer (Gamble et al., 2021), applications to a variety of target organs - including the brain - do exist.